Internal Medicine, Nephrology · Fort Worth, TX
NPI
1982651998
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1250 8th Ave, Suite 500
Fort Worth, TX, 76104
Phone (214) 358-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
5,004 services
Medicare patients, 2024
260
Average age 61
Drug cost, 2024
$717K
3,850 prescriptions
Company payments, 2025
$1,329
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angelito F Yango was code 99233 (hospital e&m - subsequent), 664 times for 112 patients. In total Angelito F Yango billed 5,004 services in 24 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 664 | 112 | $90.01 | $60K |
| 99215 Office E&M - Established | Facility | 307 | 91 | $101.52 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 279 | 76 | $12.68 | $3,539 |
| 99215 Office E&M - Established | Office | 221 | 95 | $101.77 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 192 | 94 | $12.58 | $2,416 |
| 99223 Hospital E&M - Initial | Facility | 130 | 94 | $130.30 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 98 | 34 | $60.52 | $5,931 |
| 90935 Hemodialysis | Facility | 37 | 16 | $54.83 | $2,029 |
By year: 2022 $147K for 2,171 services; 2023 $136K for 3,065 services; 2024 $151K for 5,004 services.
Medicare prescription drug claims, 2024
In 2024, the drug Angelito F Yango prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 760 prescriptions and refills. In total Angelito F Yango wrote 3,850 Medicare prescriptions that cost $717K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 760 | 1,082 | 158 | $5,757 |
| Prednisone Generic | 531 | 760 | 110 | $2,523 |
| Pantoprazole Sodium Generic | 293 | 403 | 69 | $1,982 |
| Carvedilol Generic | 191 | 260 | 36 | $877 |
| Nifedipine Er Nifedipine | 168 | 232 | 42 | $2,908 |
| Amlodipine Besylate Generic | 128 | 202 | 30 | $508 |
| Bumetanide Generic | 77 | 124 | 21 | $2,192 |
| Furosemide Generic | 75 | 119 | 24 | $381 |
| Valganciclovir Hcl Generic | 70 | 81 | 29 | $12K |
| Famotidine Generic | 68 | 132 | 15 | $546 |
| Mycophenolic Acid Mycophenolate Sodium | 63 | 83 | 12 | $13K |
| Hydralazine Hcl Generic | 60 | 95 | 19 | $455 |
| Alendronate Sodium Generic | 59 | 115 | 13 | $329 |
| Tacrolimus Generic | 58 | 74 | 12 | $3,276 |
| Lisinopril Generic | 58 | 111 | 16 | $269 |
Brand drugs: 213 claims; generic drugs: 3,607 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angelito F Yango $1,329 ($1,329 in general payments such as food, travel and fees) from 21 companies. The largest payer was Amgen Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 16 | $273 |
| Travere Therapeutics, Inc. TVTX | 6 | $148 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $113 |
| Veloxis Pharmaceuticals, Inc. | 3 | $92.86 |
| Vifor Pharma, Inc. | 3 | $82.12 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80.21 |
| Novo Nordisk Inc NVO | 3 | $68.54 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $64.11 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $52.67 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $50.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.